Revance Therapeutics (RVNC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RVNC | FHTX | UPB | ||
| Company | Revance Therapeutics | Foghorn Therapeutics Inc | Upstream Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.65 | 6.47 | 6.95 | ||
| High | 3.66 | 6.60 | 7.02 | ||
| Low | 3.65 | 6.15 | 6.80 | ||
| Last | 3.65 | 6.20 | 6.90 | ||
| Change | +0.01 | -0.29 | -0.01 | ||
| Percent Change | +0.27% | -4.47% | -0.14% | ||
| Volume | 4,123,100 | 30,961 | 39,997 | ||
| 20-Day Average Volume | 2,900,350 | 211,309 | 580,486 | ||
| Previous | 3.64 | 6.49 | 6.91 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.53 | 5.40 | 6.74 | ||
| 20-Day Raw Stochastic | 89.36% | 73.62% | 48.45% | ||
| 20-Day Relative Strength | 52.71 | 61.64 | 47.51 | ||
| Weighted Alpha | -53.44 | +9.23 | -23.92 | ||
| Today's Opinion | 24% Sell | 56% Buy | 56% Sell | ||
| Yesterday's Opinion | 24% Sell | 56% Buy | 56% Sell | ||
| Last Month's Opinion | 88% Sell | 40% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.27% since 01/29/25 | +2.22% since 08/07/26 | -5.24% since 08/07/26 | ||
| Low | 3.62 on 01/30/25 | 5.95 on 08/10/26 | 6.84 on 08/14/26 | ||
| High | 3.66 on 02/05/25 | 6.85 on 08/12/26 | 7.70 on 08/11/26 | ||
| 1-Month | |||||
| %Chg | +18.12% since 01/03/25 | +15.33% since 07/14/26 | -3.78% since 07/14/26 | ||
| Low | 3.23 on 01/10/25 | 4.41 on 07/31/26 | 6.09 on 07/28/26 | ||
| High | 3.70 on 01/17/25 | 6.85 on 08/12/26 | 7.70 on 08/11/26 | ||
| 3-Month | |||||
| %Chg | -37.50% since 11/05/24 | +53.59% since 05/14/26 | -21.84% since 05/14/26 | ||
| Low | 3.01 on 12/09/24 | 3.54 on 06/03/26 | 5.85 on 06/12/26 | ||
| High | 5.97 on 11/06/24 | 6.85 on 08/12/26 | 9.14 on 05/15/26 | ||
| 6-Month | |||||
| %Chg | +19.28% since 08/05/24 | +11.80% since 02/13/26 | -21.49% since 02/13/26 | ||
| Low | 2.80 on 08/07/24 | 3.54 on 06/03/26 | 5.85 on 06/12/26 | ||
| High | 6.65 on 08/19/24 | 6.85 on 08/12/26 | 10.67 on 04/10/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 381,023 | 385,409 | 378,468 | ||
| Shares Outstanding, K | 104,390 | 59,385 | 54,771 | ||
| Annual Sales, $M | 234,040,000 | 30,910,000 | 2,850,000 | ||
| Annual Net Income, $M | -323,990,000 | -74,280,000 | -143,440,000 | ||
| Last Qtr Sales, $M | 59,880,000 | 16,070,000 | 1,030,000 | ||
| Last Qtr Income, $M | -38,120,000 | -7,190,000 | -40,590,000 | ||
| 60-Month Beta | 0.90 | 2.89 | 1.26 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.37 on 11/07/24 | -0.10 on 08/06/26 | -0.73 on 08/11/26 | ||
| Latest Earnings Date | 02/26/25 | 11/04/26 | 11/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||